TRUTAKNA
Live / Applied — Second extension granted (statement of use) (as of 27 Mar 2026)
What this means for you
Not registered yet, but its 10 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98641742
- Mark type
- Stylized text
- Filed
- 10 Jul 2024
- Published for opposition
- 18 Feb 2025
- Attorney of record
- Colette A. Ghazarian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune and inflammation-related diseases; therapeutic preparations for the treatment of autoimmune and inflammation-related diseases
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; Medical and scientific research, namely, conducting clinical trials for others
Owner
- Vera Therapeutics, Inc., Brisbane, CA, US
- Vera Therapeutics, Inc., Brisbane, CA, US
Prosecution history
- 27 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2026 — SOU EXTENSION 2 GRANTED
- 27 Mar 2026 — SOU EXTENSION 2 FILED
- 27 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2025 — SOU EXTENSION 1 GRANTED
- 12 Sept 2025 — SOU EXTENSION 1 FILED
- 12 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Feb 2025 — PUBLISHED FOR OPPOSITION
- 12 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED